Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth P Henske

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Nature Medicine|April 6, 2013
Metabolic reprogramming in polycystic kidney diseaseCarmen Priolo, Elizabeth P Henske
Urologic Oncology|May 24, 2020
Chromophobe renal cell carcinoma: New genetic and metabolic insightsLong Zhang, Elizabeth P Henske
Nature Cell Biology|September 12, 2022
Keeping up with the Rag GTPasesNicola Alesi, Elizabeth P Henske
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|July 29, 2018
Pulmonary manifestations in tuberous sclerosis complexNishant Gupta, Elizabeth P Henske
Oncogene|November 17, 2005
Tuberous sclerosis complex: linking growth and energy signaling pathways with human diseaseAristotelis Astrinidis, Elizabeth P Henske
The European Respiratory Journal|November 3, 2018
Vitamin D binding protein: a new biomarker of disease severity in lymphangioleiomyomatosisHeng-Jia Liu, Elizabeth P Henske
European Respiratory Review : an Official Journal of the European Respiratory Society|March 5, 2014
Towards personalised therapy for lymphangioleiomyomatosis: lessons from cancerSouheil El-Chemaly, Elizabeth P Henske
Science (New York, N.Y.)|January 27, 2022
Modeling tuberous sclerosis with organoidsRebecca A Ihrie, Elizabeth P Henske
The Journal of Clinical Investigation|November 2, 2012
Lymphangioleiomyomatosis - a wolf in sheep's clothingElizabeth P Henske, Francis X McCormack
Expert Review of Respiratory Medicine|March 12, 2015
The next breakthrough in LAM clinical trials may be their design: challenges in design and execution of future LAM clinical trialsSouheil El-Chemaly, Elizabeth P Henske
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Nature Medicine|April 6, 2013
Metabolic reprogramming in polycystic kidney diseaseCarmen Priolo, Elizabeth P Henske
Urologic Oncology|May 24, 2020
Chromophobe renal cell carcinoma: New genetic and metabolic insightsLong Zhang, Elizabeth P Henske
Nature Cell Biology|September 12, 2022
Keeping up with the Rag GTPasesNicola Alesi, Elizabeth P Henske
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|July 29, 2018
Pulmonary manifestations in tuberous sclerosis complexNishant Gupta, Elizabeth P Henske
Oncogene|November 17, 2005
Tuberous sclerosis complex: linking growth and energy signaling pathways with human diseaseAristotelis Astrinidis, Elizabeth P Henske
The European Respiratory Journal|November 3, 2018
Vitamin D binding protein: a new biomarker of disease severity in lymphangioleiomyomatosisHeng-Jia Liu, Elizabeth P Henske
European Respiratory Review : an Official Journal of the European Respiratory Society|March 5, 2014
Towards personalised therapy for lymphangioleiomyomatosis: lessons from cancerSouheil El-Chemaly, Elizabeth P Henske
Science (New York, N.Y.)|January 27, 2022
Modeling tuberous sclerosis with organoidsRebecca A Ihrie, Elizabeth P Henske
The Journal of Clinical Investigation|November 2, 2012
Lymphangioleiomyomatosis - a wolf in sheep's clothingElizabeth P Henske, Francis X McCormack
Expert Review of Respiratory Medicine|March 12, 2015
The next breakthrough in LAM clinical trials may be their design: challenges in design and execution of future LAM clinical trialsSouheil El-Chemaly, Elizabeth P Henske
Pageof 15